In vitro susceptibility to linezolid in methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococcus strains;Meti̇si̇li̇ne didot;rençli staphylococcus aureus ve vankomi̇soi̇ne di̇rencli̇ enterokok suşlarinin i̇n vi̇tro li̇nezoli̇d duyarliliǧi

Mikrobiyoloji Bulteni

Volumn 43, Issue 4, 2009, Pages 639-643

  Efe, Sirin ^a   Sinirtaş, Melda ^b   Özakin, Cüneyt ^b  

^a Klinik Mikrobiyoloji ve   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Linezolid; Methicillin resistant S.aureus; Turkey; Vancomycin resistant enterococcus

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROCOCCUS FAECIUM; GRAM POSITIVE INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 73149108887     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tünger A. Staphylococcus aureus: mikrobiyoloji, patogenez ve epidemiyoloji, s: 9-22. Ulusoy S, Usluer G, Ünal S (ed), Gram Pozitif Bakteri Enfeksiyonlari. 2004. Bilirnsel Tip Yayinevi, Ankara.
2. Baysallar M, Kiliç A, Aydoǧan H, Çilli F, Doǧanci L. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Int J Antimicrob Agents 2004;23:510-2.
3. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40:135-6.
4. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:765-6.
5. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001;7:327-32.
6. Başustaoǧlu A. Enterokoklarda antibakteriyel direnç mekanizmalari ve direnç sorunu, s: 141-58. Ulusoy S, Usluer G, Ünal S (ed), Gram Pozitif Bakteri Enfeksiyonlan. 2004. Bilirnsel Tip Yayinevi, Ankara.
7. Livermore DM. Linezolid in vitro: mechanism and antibacterial spectrum. J Antimicrob Chemother 2003;51(Suppl 2):ii9-16.
8. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42.
9. Bozdogan B, Appelbaum PC. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 2004;23:113-9.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement, M100-S16. 2006. CLSI, Wayne, PA.
11. Tünger A, Aydemir S, Uluer S, Cilli F. In vitro activity of linezolid & quinupristin/dalfopristin against Grampositive cocci. Indian J Med Res 2004;120:546-52.
12. Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR. In vitro activities of linezolid against important gram positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999;43:2059-62.
13. Stefani S, Mezzatesta ML, Tempera G, et al. Comparative activity of linezolid against staphylococci and enterococci isolated in Italy. Clin Microbiol Infect 2002;8:368-72.
14. Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patents. J Antimicrob Chemother 2006;58:470-3.
15. Dizbay M, Sipahi AB, Günal Ö ve ark. Metisiline dirençli Staphylococcus aureus izolatlarinda glikopeptid ve linezolid direncinin araştirilmasi. ANKEM 2007;21:23-6.
16. Dilek AR, Yildiz F, Dilek N, Bulut Y, Toraman ZA. Linezolidin MRSA ve Enterococcus spp. suşlarina in vitro etkinliǧi ANKEM 2007;21:211-3.
17. Kanan B, Akşit F, Kiremitçi A. Gram pozitif koklara karşi linezolidin in vitro aktivitesinin deǧerlendirilmesi. Türk Mikrobiyol Cem Derg 2006;36:25-30.